Skip to Content

475 (Imatinib Mesylate 400 mg)

Pill with imprint 475 is Yellow, Elliptical / Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Sun Pharma Global FZE.

Imatinib is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 475

Imatinib Mesylate

Imprint
475
Strength
400 mg
Color
Yellow
Size
20.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sun Pharma Global FZE
National Drug Code (NDC)
47335-0475
Inactive Ingredients
microcrystalline cellulose, mannitol, copovidone, crospovidone, magnesium stearate, hypromelloses, ferric oxide yellow, polyethylene glycol, titanium dioxide, FD&C Yellow No. 6, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "475"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.